ArticleBMC cancer2025

Analytical performance of OncoPrism-HNSCC, an RNA-based assay to inform immune checkpoint inhibitor treatment decisions for recurrent/metastatic head and neck squamous cell carcinoma.

Jeffrey Hiken et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.